NCT05565638View on ClinicalTrials.gov

PROFAST Intervention in Precursor Multiple Myeloma

NACompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

March 6, 2023

Primary Completion Date

August 4, 2025

Study Completion Date

August 4, 2025

Conditions
Cancer PreventionWeight LossSmoldering Waldenstrom Macroglobulinemia(WM)MGUSFastingMultiple Myeloma
Interventions
BEHAVIORAL

Prolonged Fasting Intervention

promote a 14-hour fast during the nighttime hours

BEHAVIORAL

EDUCATION CONTROL

introductory session with a health coach and educational information will be provided. Participants will also receive one email and one text message per week with tips on healthy living

Trial Locations (1)

02115

Dana Farber Cancer Institute, Boston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Dana-Farber Cancer Institute

OTHER